SporeGen® announces update from research collaboration under Innovate UK grant award to develop a biotherapeutic treatment (SPOR-COV®) for COVID-19 and Influenza
- May 08, 2023
· SPOR-COVTM prophylactic approach targets the innate immune system with potential to develop COVID-19 protection within a few days of treatment
· Innovate UK grant of £800,000 to support SPOR-COV programme over the next 18 months
Read More